Most Popular Stories

Published August 30, 2013

Most Popular Stories
Tolvaptan is in development as a treatment to slow the progression of kidney disease for patients at risk of rapidly progressing ADPKD.1 Tolvaptan was studied in patients with enlarged kidneys who were in chronic kidney disease (CKD) stages 1-3 at … Read more on The Herald | HeraldOnline.com

Panel pushes ways to cut overdoses in Wicomico
Maciarello said the problem won't go away if it is temporarily solved; instead, programs that deal with the addiction — such as drug court — are more helpful in the long-term. He also talked about … He said he was encouraged to see the number of … Read more on Delmarva Now